News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Thomas Gallagher Speaks On How Understanding Sarbanes-Oxley, Industry Compliance Guidance And The Changing Organizational Sentencing Guidelines Affect Government Investigations Of Pharmaceutical Companies At Institute for International Research Conference



10/19/2005 5:11:12 PM

The Sarbanes-Oxley Act of 2002 was passed in the wake of Enron and other corporate accounting scandals to prevent ethics scandals and other governance problems from recurring and to rebuild public trust in corporate business and reporting practices. The new Act is dramatically altering the legal and compliance landscape for the pharmaceutical industry.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES